Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura — diagnostic difficulties and errors

   Introduction. When establishing a diagnosis of thrombotic thrombocytopenic purpura (TTP) for the first time, other diseases occurring with thrombocytopenia may be misdiagnosed.

   Aim: to analyze diagnostic difficulties and errors of TTP.

   Materials and methods. In total, 54 patients (44 women and 10 men) aged 18 to 83 years (median 33 years), who were diagnosed TTP from 2019 to 2023, were included in the study. Anamnesis, baseline hemoglobin, platelets, erythrocytes, lactate dehydrogenase and bilirubin serum concentrations, pre-established diagnoses, treatment, and outcomes were analyzed.

   Results. Initially TTP was suspected only in 19 (35 %) patients. In 12 out of 54 patients immune thrombocytopenia (ITP) was initially misdiagnosed. Fisher-Evans syndrome was initially suspected in 3 patients. In sporadic cases, myelodysplastic syndrome, systemic lupus erythematosus / antiphospholipid syndrome, autoimmune hemolytic anemia were initially suspected. Among 15 women with associated with pregnancy TTP in 8 (53.3 %), HELLP syndrome was initially misdiagnosed. In total, 12 (22.2 %) of 54 TTP patients died. In 11/12 non-survival patients, TTP treatment was never started, because the doctors were waiting for the ADAMTS13 test results. A case report of Sequential Immune Thrombocytopenia (ITP) and TTP in the same Patient is described.

   Conclusion. When thrombocytopenia is combined with hemolysis and in the absence of multiple organ pathology, it is difficult to differentiate ITP and TTP without examining the plasma activity of ADAMTS113. With a combination of ITP and TTP in the same patient, the study of ADAMTS13 plasma activity makes it possible to identify the leading mechanism of thrombocytopenia and choose treatment tactics.

1. Jones H.W., Tocantins L.M. The history of purpura hemorrhagica. Ann Med Hist. 1933; 5: 349–59.

2. Lusitanus A. Curationum medicinalium centuriae duae tertia et quanta. In: Major RH, editor. Classic Descriptions of Disease. 3^rd ed. Lyons, Rouillium: Springfield, IL, CC Thomas; 1965. P. 254.

3. Riverius L. Praxis Medica or the Compleat Practice of Physick. London: Streator; 1668. 618 p.

4. Werlhof P.G. Opera omnia. In: Major RH, editor. Classic Descriptions of Disease. 3^rd ed. Hanover, Helwing: Springfi eld, IL, CC Thomas; 1965. P. 618.

5. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. An undescribed disease. Am J Med. 1952; 13(5): 567–9. DOI: 10.1016/0002-9343(52)90022-3.

6. Frank E. Die essentielle thrombopenie (Konstitutionelle Purpura-Pseudohamophilie). Berl Klin Wochenschr. 1915; 52: 454–8.

7. Minot G.R. Studies on a case of idiopathic purpura hemorrhagica. Am J Med Sci. 1916; 152: 48–65.

8. Kaznelson P. Verschwinden der hämorrhagischen Diathese bei einem Falle von “essentieller Thrombopenie”. Wien Klin Wochenschr. 1916; 29: 1451–4.

9. Troland C.E., Lee F.C. Thrombocytopen, a substance in the extract from the spleen of patients with idiopathic thrombocytopenic purpura that reduces the number of blood platelets. JAMA. 1938; 111: 221–6.

10. Dameshek W., Miller E.B. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood. 1946; 1: 27–50.

11. Harrington W.J., Minnich V., Hollingsworth J.W., et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951; 38: 1–10.

12. Evans R.S., Kazuyuki T., Duane R.T., et al. Primary thrombocytopenic purpura and acquired hemolytic anemia: Evidence for a common etiology. Arch Intern Med. 1951; 87: 48–65.

13. Furlan M., Robles R., Lämmle B., et al. Partial purifi cation and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996; 87(10): 4223–34. DOI: 10.1182/blood.v87.10.4223.bloodjournal87104223.

14. Melikyan A.L., Pustovaya E.I., Egorova E.K., et al. Differential diagnosis of thrombocytopenes. Onkogematologiya. 2017; 12(1): 78–87 (In Russian). DOI: 10.17650/1818-8346-2017-12-1-78-87.

15. Melikyan A.L., Pustovaya E.I., Tsvetaeva N.V. et al. National clinical recommendations for diagnosis and therapy of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia) in adults (2016). Gematologiya I Transfusiologiya. 2017; 62(1) Suppl 1: 1–60 (In Russian). URL: https://elibrary.ru/item.asp?edn=trkdhd&ysclid=lozphz3rer621730405.

16. Scully M., Hunt B.J., Benjamin S., et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012; 158(3): 323–35. DOI: 10.1111/j.1365-2141.2012.09167.x.

17. Mariotte E., Azoulay E., Galicier L., et al. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016; 3(5): e237–45. DOI: 10.1016/S2352-3026(16)30018-7.

18. Rudowski W.J. Accessory spleens: Clinical signifi cance with particular reference to the recurrence of idiopathic thrombocytopenic purpura. World J Surg. 1985; 9: 422–30.

19. Kulagin A.D., Klimova O.U., Dobronravov A.V., et al. Clinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A case series of 150 patients Klinicheskaya onkogematologiya. 2017; 10(3): 333–41 (In Russian). DOI: 10.21320/2500-2139-2017-10-3-333-341.

20. Coppo P., Schwarzinger M., Buffet M., et al. Predictive features of severe acquired ADAMTS13 defi ciency in idiopathic thrombotic microangiopathies: The French TMA reference center experience. PLoS One. 2010; 5(4): e1028. DOI: 10.1371/journal.pone.0010208.

21. Bendapudi P.K., Hurwitz S., Fry A., et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017; 4(4): e157–64. DOI: 10.1016/S2352-3026(17)30026-1.

22. Galstyan G.M., Klebanova E.E., Mamleeva S.Yu., et al. Neurological disorders in patients with thrombotic thrombocytopenic purpura. Klinicheskaya meditsina. 2023; 101(1): 41–9 (In Russian). DOI: 10.30629/0023-2149-2023-101-1-41-49.

23. Lim M.Y., Abou-Ismail M.Y., Branch D.W. Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol. 2023; 141(1): 85–108. DOI: 10.1097/AOG.0000000000005024.

24. Fakhouri F., Scully M., Provot F., et al. Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an international working group. Blood. 2020; 136(19): 2103–17. DOI: 10.1182/BLOOD.2020005221.

25. Yamada Y., Ohbe H., Yasunaga H., et al. Clinical Practice Pattern of Acquired Thrombotic Thrombocytopenic Purpura in Japan: A nationwide Inpatient Database Analysis. Blood. 2019; 134(Suppl 1): 2374. DOI: 10.1182/blood-2019-125170.

26. Kremer Hovinga J.A., Vesely S.K., Terrell D.R., et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010; 115(8): 1500–11. DOI: 10.1182/blood-2009-09-243790.

27. Zacharski L.R., Lusted D., Glick J.L. Thrombotic thrombocytopenic purpura in a previously splenectomized patient. Am J Med. 1976; 60(7): 1061–3. DOI: 10.1016/0002-9343(76)90581-7.

28. Stein R.S., Flexner J.M. Idiopathic thrombocytopenic purpura during remission of thrombotic thrombocytopenic purpura. South Med J. 1984; 77(12): 1599–601. DOI: 10.1097/00007611-198412000-00034.

29. Meisenberg B.R., Robinson W.L., Mosley C.A., et al. Thrombotic thrombocytopenic purpura in human immunodefi ciency (HIV)‐seropositive males. Am J Hematol. 1988; 27(3): 212–5. DOI: 10.1002/ajh.2830270312.

30. Krupsky M., Sarel R., Hurwitz N., et al. Late appearance of thrombotic thrombocytopenic purpura after autoimmune hemolytic anemia and in the course of chronic autoimmune thrombocytopenic purpura: two case reports. Acta Haematol. 1991; 85: 139–42. DOI: 10.1159/000204876.

31. Routy J. P., Beaulieu R., Monte M., et al. Immunologic thrombocytopenia followed by thrombotic thrombocytopenic purpura in two HIV1 patients. Am J Hematol. 1991; 38(4): 327–8. DOI: 10.1002/ajh.2830380414.

32. Shivaram U., Cash M. Purpura fulminans, metastatic endophthalmitis, and thrombotic thrombocytopenic purpura in an HIV-infected patient. NY State J Med. 1992; 92(7): 313–4.

33. Olenich M., Schattner E. Postpartum thrombotic thrombocytopenic purpura (TTP) complicating pregnancy-associated immune thrombocytopenic purpura (ITP). Ann Intern Med. 1994; 120(10): 845–7. DOI: 10.7326/0003-4819-120-10-199405150-00005.

34. Yospur L.S., Sun N.C.J., Figueroa P., et al. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: Case report and review of the literature. Am J Hematol. 1996; 51(1): 73–8. DOI: 10.1002/(SICI)1096-8652(199601)51:1<73::AID-AJH12>3.0.CO;2-C.

35. Manner C.E., Gathe J.J., Novak I., et al. Thrombotic thrombocytopenic purpura (TTP) in a man with AIDS and prior idiopathic thrombocytopenic purpura (ITP). Int Conf AIDS. 1993; 9(1): 451.

36. Prasad V.K., Kim I.K., Farrington K., et al. TTP following ITP in an HIV-positive boy. J Pediatr Hematol Oncol. 1996; 18(4): 384–6. DOI: 10.1097/00043426-199611000-00010.

37. Baron B.W., Martin M. Saint, Sucharetza B.S., et al. Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: The concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange. J Clin Apher. 2001; 16(4): 179–85. DOI: 10.1002/jca.1031.

38. Bayraktar S., Eileen B., Shariatmadar S., et al. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP. BMJ Case Rep. 2010; 2010: 1–3. DOI: 10.1136/bcr.07.2010.3144.

39. Changela A., Jagarlamudi K., Villani G., et al. Thrombotic thrombocytopenic purpura complicating immune thrombocytopenic purpura-A case report. Am J Hematol. 2011; 86(4): 383. DOI: 10.1002/ajh.21971.

40. Farhat M.H., Kuriakose P., Jawad M., et al. Sequential occurrence of thrombotic thrombocytopenic purpura, essential thrombocythemia, and idiopathic thrombocytopenic purpura in a 42-year-old African-American woman: A case report and review of the literature. J Med Case Rep. 2012; 6(1): 93. DOI: 10.1186/1752-1947-6-93.

41. Al-Husban N., Al-Kuran O. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature. J Med Case Rep. 2018; 12: 147. DOI: 10.1186/s13256-018-1692-1.

42. Miller D.D., Krenzer J.A., Kenkre V.P., et al. Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score. Case Rep Med. 2021; 2021. DOI: 10.1155/2021/6869342.

43. Ge H., Shi Z., Zheng Z., et al. Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report. J Int Med Res. 2022; 50(3): 1–8. DOI: 10.1177/03000605221085127.

44. Lin H.C., Huang J., Huang J., et al. Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature. J Med Case Rep. 2023; 17(1): 10–7. DOI: 10.1186/s13256-023-03762-y.

45. Zini G., D’Onofrio G., Erber W.N., et al. 2021 update of the 2012 ICSH Recommendations for identifi cation, diagnostic value, and quantitation of schistocytes: Impact and revisions. Int J Lab Hematol. 2021; 43(6): 1264–71. DOI: 10.1111/ijlh.13682.

46. Cuker A., Cataland S.R., Coppo P., et al. Redefi ning Outcomes in Immune TTP: an International Working Group Consensus Report. Blood. 2021; 137(14): 1855–61. DOI: 10.1182/blood.2020009150.